Company* (Country; Symbol)


Type/Product Area

Terms/Details (Date)

Epoch Biosciences Inc. (EBIO)

Associated Regional and University Pathologists Inc.

Epoch will supply the national reference laboratory its MGB Eclipse Detection Reagents

They will collaborate on development and validation of infectious disease assays for use in the laboratory (5/4)

Harvard Bioscience Inc. (HBIO)

The Automation Partnership* (UK)

Deal to incorporate Harvard's microscopy reader technology into TAP's Cello cell culture system

The deal involves technology from Harvard subsidiary MAIA Scientific; terms were not disclosed (5/3)

Orchid BioSciences Inc. (ORCH)

Cybergenetics Corp.*

The Orchid Cellmark unit licensed Cybergenetics' TrueAllele software for forensics applications

Terms of the deal were not disclosed; it is the first licensing of the technology by a private U.S. laboratory (5/3)

Paradigm Genetics Inc. (PDGM)

Experimental Pathology Laboratories Inc.

Collaboration to further develop Paradigm's automated pathology software

The software will be installed at EPL, which also will serve as the contact for Paradigm's clients on veterinary pathology topics; a broader deal is being discussed (6/22)

Tarpan Therapeutics Inc.*

IGI Inc. (AMEX:IG) delivery technology

Tarpan got a sublicense for use of PTH 1-34 to treat skin disorders using IGI's Novasome

IGI gets an up-front payment and potential milestones and royalties; Tarpan assumes all clinical trial costs (5/4)


* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

No Comments